Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics.

Hüttenhain R, Soste M, Selevsek N, Röst H, Sethi A, Carapito C, Farrah T, Deutsch EW, Kusebauch U, Moritz RL, Niméus-Malmström E, Rinner O, Aebersold R.

Sci Transl Med. 2012 Jul 11;4(142):142ra94. doi: 10.1126/scitranslmed.3003989.

2.

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.

Niméus-Malmström E, Koliadi A, Ahlin C, Holmqvist M, Holmberg L, Amini RM, Jirström K, Wärnberg F, Blomqvist C, Fernö M, Fjällskog ML.

Int J Cancer. 2010 Aug 15;127(4):961-7. doi: 10.1002/ijc.25091.

3.

Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy.

Niméus-Malmström E, Krogh M, Malmström P, Strand C, Fredriksson I, Karlsson P, Nordenskjöld B, Stål O, Ostberg G, Peterson C, Fernö M.

Breast Cancer Res. 2008;10(2):R34. doi: 10.1186/bcr1997. Epub 2008 Apr 22.

4.

Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy.

Niméus-Malmström E, Ritz C, Edén P, Johnsson A, Ohlsson M, Strand C, Ostberg G, Fernö M, Peterson C.

Eur J Cancer. 2006 Nov;42(16):2729-37. Epub 2006 Oct 4.

PMID:
17023159

Supplemental Content

Loading ...
Support Center